Literature DB >> 11160144

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

A S Baldwin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11160144      PMCID： PMC199203          DOI： 10.1172/JCI11991

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  47 in total

Review 1.  Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex.

Authors:  E Zandi; M Karin
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 2.  Control of apoptosis by Rel/NF-kappaB transcription factors.

Authors:  M Barkett; T D Gilmore
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

3.  NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B.

Authors:  James C. Cusack; Rong Liu; Albert S. Baldwin
Journal:  Drug Resist Updat       Date:  1999-08       Impact factor: 18.500

Review 4.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.

Authors:  P Ciana; A Neri; C Cappellini; F Cavallo; M Pomati; C C Chang; A T Maiolo; L Lombardi
Journal:  Oncogene       Date:  1997-04-17       Impact factor: 9.867

6.  Role of NF-kappaB in p53-mediated programmed cell death.

Authors:  K M Ryan; M K Ernst; N R Rice; K H Vousden
Journal:  Nature       Date:  2000-04-20       Impact factor: 49.962

Review 7.  Aberrant rel/nfkb genes and activity in human cancer.

Authors:  B Rayet; C Gélinas
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

8.  Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.

Authors:  S Kasibhatla; L Genestier; D R Green
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

9.  DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

Authors:  S Kasibhatla; T Brunner; L Genestier; F Echeverri; A Mahboubi; D R Green
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

10.  Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.

Authors:  H Ishikawa; D Carrasco; E Claudio; R P Ryseck; R Bravo
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307
View more
  368 in total

Review 1.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 2.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 3.  NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer.

Authors:  Hana Algül; Guido Adler; Roland M Schmid
Journal:  Int J Gastrointest Cancer       Date:  2002

4.  The NFkappaB luciferase mouse: a new tool for real time measurement of NFkappaB activation in the whole animal.

Authors:  D A Mann
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

5.  IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.

Authors:  Yanxia Ning; Rebecca B Riggins; Jennifer E Mulla; Haniee Chung; Alan Zwart; Robert Clarke
Journal:  Mol Cancer Ther       Date:  2010-05       Impact factor: 6.261

6.  Conditional ablation of Ikkb inhibits melanoma tumor development in mice.

Authors:  Jinming Yang; Ryan Splittgerber; Fiona E Yull; Sara Kantrow; Gregory D Ayers; Michael Karin; Ann Richmond
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

7.  Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis.

Authors:  Bao-Song Zhu; Chun-Gen Xing; Fang Lin; Xiao-Qing Fan; Kui Zhao; Zheng-Hong Qin
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

Review 8.  NF-kappaB, a pivotal transcription factor in silica-induced diseases.

Authors:  Fei Chen; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  Nuclear factor-κB activation in primary lymphoma of bone.

Authors:  Lianne Koens; Fenna H Heyning; Agota Szepesi; András Matolcsy; Pancras C W Hogendoorn; Patty M Jansen
Journal:  Virchows Arch       Date:  2013-01-19       Impact factor: 4.064

10.  NF-kappaB protects from the lysosomal pathway of cell death.

Authors:  Ni Liu; Srikumar M Raja; Francesca Zazzeroni; Sunil S Metkar; Ramila Shah; Manling Zhang; Yue Wang; Dieter Brömme; William A Russin; Justine C Lee; Marcus E Peter; Christopher J Froelich; Guido Franzoso; Philip G Ashton-Rickardt
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.